Your session is about to expire
← Back to Search
NIRAF Detection for Parathyroid Disorders (NIRAF Trial)
NIRAF Trial Summary
This trial found that using NIRAF detection with PTeye during PTx was not associated with significantly greater risk-benefits or outcomes compared to not using NIRAF detection with PTeye during PTx.
- Primary Hyperparathyroidism
- Parathyroid Adenomas
- Parathyroid Tumors
- Parathyroid Hyperplasia
- Parathyroid Cancer
- Hypercalcemia
NIRAF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NIRAF Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have secondary or tertiary hyperparathyroidism.You have already had surgery for a certain condition, but it didn't work.You have both parathyroid and thyroid disease and need to have your entire thyroid removed.People with primary hyperparathyroidism who are eligible for surgery to remove the parathyroid gland can participate. The type of surgery (bilateral or focused) will be decided by the surgeon.
- Group 1: NIRAF Detection Technology +
- Group 2: NIRAF Detection Technology -
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does my profile meet the requirements to participate in this research?
"This trial is open to patients with parathyroid adenomas, aged 18 or older and below 99 years old. The study requires the participation of around 160 volunteers."
What are the primary goals that this experiment seeks to accomplish?
"This medical trial, which will be carried out over a given duration of time, seeks to resolve Persistent hyperparathyroidism or hypercalcemia following parathyroidectomy (PTx). Secondary objectives include determining the Number of 'false positive' tissues excised by surgeon, Duration taken for intraoperative parathyroid hormone (PTH) to normalize and the Number of diseased parathyroid glands identified versus preoperatively localized glands."
Are applicants aged 40 and over accepted for this exploratory research?
"Candidates aged 18 and younger than 99 are welcome to take part in this medical research."
Is this experimental therapy still available to participants?
"Affirmative. Clinicaltrials.gov shows that this study is actively looking for participants to join; the trial was first introduced on March 13th 2020 and recently updated on April 11th 2022. The research necessitates 160 patients from a single medical site."
Can you elaborate on the total number of participants who have signed up for this clinical trial?
"Affirmative. The records on clinicaltrials.gov indicates that, since its first posting in March 2020, this medical research is still recruiting participants from a single site for a total of 160 patients."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger